Depression, anxiety, and somatization in patients with clinical and subclinical hypothyroidism: An exploratory study

Kale, Kavita Sanjiv; Baviskar, B. P.

doi:10.4103/trp.trp_42_17

Cited by 4 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SSD is common, associated with persistent symptoms, individual and societal burden, high levels of healthcare utilisation and economic cost. 38 Yet there is little information in the literature about SSD in hypothyroidism, 39,40 while impaired quality of life and dissatisfaction with care and treatment are well documented. [41][42][43][44] We used the validated PHQ-15 questionnaire 31 characteristics were similar to hypothyroid patient populations reported in the literature.…”

Section: Discussionmentioning

confidence: 99%

Hypothyroidism and Somatization: Results from E-Mode Patient Self-Assessment of Thyroid Therapy, a Cross-Sectional, International Online Patient Survey

et al. 2023

View full text Add to dashboard Cite

BackgroundBetween 10-15% of hypothyroid patients experience persistent symptoms despite achieving biochemical euthyroidism. Unexplained persistent symptoms can be a sign of somatization. This is associated with distress and high healthcare resource use and can be classified as Somatic Symptom Disorder (SSD). Prevalence rates for SSD differ depending on classification criteria and how they are ascertained, varying between 4-25%. As this has not been studied in hypothyroid patients before, the aim of this study was to document somatization in people with hypothyroidism and explore associations with other patient characteristics and outcomes. Methods Online, multi-national, cross-sectional survey of individuals with selfreported, treated hypothyroidism, that included the validated patient health questionnaire-15 (PHQ-15) for assessment of somatization. Chi-

show abstract